Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.

Movement disorders : official journal of the Movement Disorder Society - 15 Feb 2009

Lane Roger, He Yunsheng, Morris Christopher, Leverenz James B, Emre Murat, Ballard Clive

Abstract excerpt

Apolipoprotein E (APOE) epsilon4 and butyrylcholinesterase-K (BuChE-K) are associated with an increased risk for Alzheimer's disease. The primary objective was to evaluate frequencies of these alleles in dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). A secondary objective was to evaluate influences on rate of cognitive decline. This analysis used data from participants consenting to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Butyrylcholinesterase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition Disorders

Share to Hyperhomocysteinemia

Share to Lewy Body Disease

Share to Neuroprotective Agents

Share to Psychomotor Disorders

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 19006190
DOI: 10.1002/mds.22357

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.PMID 19006190Read ↗

Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.Semantic proximity Read ↗

Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.Semantic proximity Read ↗

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.Semantic proximity Read ↗

No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.Semantic proximity Read ↗

Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.Semantic proximity Read ↗

Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease.Semantic proximity Read ↗

APOE E4 is associated with cognitive decline but not with disease risk or age of onset in Nigerians with Parkinson’s diseaseSemantic proximity Read ↗

APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.Semantic proximity Read ↗

Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's DiseaseSemantic proximity Read ↗

Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.Semantic proximity Read ↗

The impact of Apolipoprotein E alleles on cognitive performance in patients with Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.